Aug 11, 2014 ... FOR THE DISTRICT OF DELAWARE. In re: ) Chapter 11. ) VASO ACTIVE
PHARMACEUTICALS, INC., ). ) Case No. 10-10855 (CSS). Debtors.
Beverly Enterprises - Arkansas, Inc., et al. and Vera Cooney and Eula Mae Allen,
et al., v. Beverly ...... In re Vaso Active Pharmaceuticals Securities Litigation.
Company Name, VASO ACTIVE PHARMACEUTICALS INC. Company Address,
99 ROSEWOOD DRIVE, #260. DANVERS, MA 01923. Company Phone ...
Sep 22, 2014 ... A vasoactive role for relaxin is supported by our recent data that .... ml TriReagent
(Ambion Inc., Scoresbury, VIC, Australia) and total RNA was .... This could have
been due to differences in compositional remodeling or re-arrangement of ....
McGuane JT, Debrah JE, Sautina L, Jarajapu YPR, Novak J, et al.
A radioligand-binding assay with <sup>125</sup>I-labeled vasoactive intestinal peptide (VIP)
.... <sup>125</sup>I-Labelled VIP (81.4 TBq·mmol<sup>−1</sup>) was purchased from PerkinElmer Life
Sciences Inc. ... CSE was prepared by a modification of the method of Carp et al.
..... VIP receptors in alveolar cells could be a pharmacological drug target for the
Jun 12, 2007 ... The gene of the vasoactive intestinal peptide (VIP) is alternatively spliced ....
binding assays were performed according to Berger et al. ... Full-length human
galanin was purchased from Phoenix Pharmaceuticals (Belmont, .... Enigk RE ,;
Maimone MM ..... Video content is hosted by Glencoe Software, Inc.
ganglion (SCG) of the adult rat (Hokfelt et al., 1977; Sasek and. Zigmond, 1989).
... synthesis, depolarization of sympathetic neurons has been re- ported to inhibit
the .... by adding 1.5 PM veratridine (ICN Pharmaceuticals Inc., Plainview,. NY).
Jul 7, 2009 ... heart failure while lacking the vasoactive properties of BNP. These findings ...
Genome-wide analyses have revealed the prevalence of al- ternative .... Pan et al
. PNAS. July 7 ... As alternative splicing usually affects coding re- .... BNP (hBNP,
Phoenix Pharmaceuticals, Inc.) or ASBNP.1 (final concentration.
Abstract. In the search for mechanisms of obesity-mediated vascular pathology,
attention has been focused on the role played by adipose tissue, ...
2IPS Pharma Inc., Sherbrooke, QC, CANADA; ... vasoactive mediators such as
nitric oxide (NO) and prostaglandins. In chronic (30 ..... and ZDF fatty
prehypertensive rats, CGS 35601, at 5 mg /kg/day re- ..... Bowen T, Cicardi M,
Farkas H, et al.